4Stange E F, Travis S P L, Vermeire S, et al. European evidence based consensous on the diagnosis and management of Crohns disease:definitions and diagnosis[ J ]. Gut ,2006,55 ( Suppl 1 ) : il -i15.
5Kornbluth A,Sachar D B. Ulcerative colitis practice guidelines in adults ( update ) : American College of Gastroenterology, Practice Parameters Committee [ J ]. Am J Gastroenterol,2004,99 ( 7 ) : 1371.
6Hanauer S B. Review article:evolving concepts in treatment and disease modification in ulcerative colitis [ J ]. Aliment Pharmacol Ther, 2008,27 ( Suppl 1 ) : 15-21.
7D' Haens G, Baert F, van Assche G, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease : an open randomised trial [ J ]. Lancet, 2008, 371 (9613) :660-667.
9Yamamoto T, Nakahigashi M, Umegae S, et al. Enteral nutrition for the maintenance of remission in Crohn ~ disease : a systematic review [ J ]. Eur J Gastroenterol Hepatol,2010,22 ( 1 ) : 1-8.
10Zachos M,Tondeur M, Griffiths A M. Enteral nutritional therapy for induction of remission in Crohn ~s disease [ J ]. Cochrane Database Syst Rev ,2007,24 ( 1 ) : CD000542.
7Ghosh S. Multidisciplinary teams as standard of care in inflammatory bowel diseasej L], CanJ Gastroenterol,2013 ,27(4) :198-204.
8PanesJ 0' Connor M ,Peyrin - Biroulet L, et al. Improving quality of care in inflammatory bowel disease: What changes can be made today[J].JCC ,2014 ,8 (3) :919-926.
9Melmed G Y,Siegel C A,Spiegei B M,et aJ. Quality indicators for inflammatory bowel disease: development of processand outcome measures[J]. IBD,2013,19(3) :662-668.
10Rutgeerts P, Geboes K, Peeters M, et al. Effect of faecal faecal stream diversion on recurrence of Crohn ' s disease in the neoterminalileum[J] . Lancet ,1991,338: 771-772.
